 |
市场调查报告书
商品编码
1747508
全球伴侣动物疫苗市场按产品类型、类型、分销管道和地区划分Companion Animal Vaccine Market, By Product Type, By Species Type , By Distribution Channel, By Geography |
||||||
价格
简介目录
伴侣动物疫苗市场规模预计在 2025 年为 38.2 亿美元，预计到 2032 年将达到 60.5 亿美元，2025 年至 2032 年的复合年增长率为 6.8%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 38.2亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 6.80% | 2032年价值预测 | 60.5亿美元 |
伴侣动物疫苗在以经济有效的方式改善伴侣动物健康方面发挥着至关重要的作用。这些疫苗对于减少可在动物之间或动物之间传播的人际病毒性疾病也至关重要。美国FDA 兽医中心 (CVM)核准用于伴侣动物（例如狗、猫和马）以及食用动物（例如牛、猪和鸡）的药物。此外，预计在预测期内，对伴侣动物疾病（包括病毒性疾病）预防的监管力度不断增加将推动全球伴侣动物市场的成长。例如，2016 年，美国动物医院协会 (AAHA)委託一个由兽医肿瘤学专家组成的工作小组制定了一套指南，帮助兽医团队与宠物饲主合作制定个人化治疗计划，从而改善癌症宠物的生活品质。
市场动态
新型伴侣动物疫苗的核准和上市数量不断增加，市场主要企业采取收购和合作等无机成长策略，以及新型疫苗研发的不断推进，预计将在预测期内推动全球伴侣动物疫苗市场的成长。例如，鑑于犬利甚曼病在全球多个地区（尤其是南欧和南美）的流行率不断上升，法国动物护理公司维克（Virbac）于2019年3月推出了一款名为CANILEISH的疫苗，用于预防犬利什曼原虫症利什曼原虫症。
此外，2018 年 6 月，硕腾的 Fostera Gold PCV 获得了美国农业部的上市核准，这是第一个用于养猪业的单价疫苗，含有两种基因型的猪环状病毒2 型 (PCV2)。
本研究的主要特点
- 本报告对全球伴侣动物疫苗市场进行了详细分析，并提供了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）（假设 2024 年为基准年）。
- 它还揭示了不同领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 全球伴侣动物疫苗市场的主要企业根据公司概况、绩效、产品系列、市场影响、分销策略、关键发展、策略和未来计划等参数进行分析。
- 本报告的见解将使企业负责人和经营团队能够就未来的市场扩张和行销策略做出明智的决策。
- 全球伴侣动物疫苗市场报告针对该行业的各个相关人员，包括投资者、产品开发商和製造商、经销商、医疗机构、研发机构、新进业者和金融分析师。
- 透过用于分析全球伴侣动物疫苗市场的各种策略矩阵，相关人员可以在决策中获得显着利益。
目录
第一章 研究目的与前提
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 市场机会
- 影响分析
- 产品发布/核准
- 流行病学
- 合併、收购和合作
- 监管情景
- 主要进展
- PEST分析
4. 2020 年至 2032 年全球伴侣动物疫苗市场（依产品类型）
- 减毒活病毒疫苗
- 结合疫苗
- 灭活疫苗
- 次单位疫苗
- 类毒素疫苗
- DNA疫苗
- 重组疫苗
5. 2020 年至 2032 年全球伴侣动物疫苗市场（按类型）
- 狗
- 猫
- 马
- 鸟类
- 其他的
6. 2020 年至 2032 年全球伴侣动物疫苗市场（依通路）
- 兽医诊所
- 兽医诊所
- 兽医研究所
- 其他的
7. 2020 年至 2032 年全球伴侣动物疫苗市场（按地区）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中东
- GCC
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第八章 竞争态势
- 公司简介
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck &Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, as
第九章 章节
- 参考
- 调查方法
简介目录
Product Code: CMI3387
The Companion Animal Vaccine Market is estimated to be valued at USD 3.82 Bn in 2025 and is expected to reach USD 6.05 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.82 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | USD 6.05 Bn |
Companion animal vaccines play an important role in improving the health of companion animals in a cost effective manner. These vaccines are also important for reducing viral diseases transmitted from animals to animals or animals to humans. The U.S. FDA Center for Veterinary Medicine (CVM) approves drugs for companion (pet) animals such as dogs, cats, and horses and for food-producing animals such as cattle, pigs, and chickens. Moreover, increasing initiatives from regulatory authorities for prevention of diseases such as viral diseases in companion animals are expected to boost the global companion animal market growth over the forecast period. For instance, in 2016, The American Animal Hospital Association (AAHA) has commissioned a task force of veterinary oncology experts to develop a set of guidelines that will help veterinary teams work with pet owners for tailored treatment plans that will improve the quality of life of pets with cancer.
Market Dynamics
The increasing approval and launch of novel companion vaccines, adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, and rising research and development of novel vaccines are expected to drive the growth of global companion animal vaccine market over the forecast period. For instance, in March 2019, Virbac, a French animal care company, launched a vaccine called CANILEISH to prevent canine leishmaniosis, due to the increasing prevalence of canine leishmaniosis in several regions across the globe, especially in Southern Europe and South America.
Moreover, in June 2018, Zoetis received approval from the U.S. Department of Agriculture for marketing its first monovalent vaccine Fostera Gold PCV, used in the pork industry for swine that includes two genotypes of porcine circovirus type 2 (PCV2).
Key features of the study
- This report provides in-depth analysis of the global companion animal vaccine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global companion animal vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Virbac, Zoetis Inc, HIPRA, Biogenesis Bago, and Ourofino Animal Health.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
- The global companion animal vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
- Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global companion animal vaccine market.
Market Segmentation
- Global Companion Animal Vaccine Market, By Product Type
- Attenuated Live Vaccine
- Conjugate Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- DNA Vaccine
- Recombinant Vaccine
- Global Companion Animal Vaccine Market, By Animal Type
- Canine
- Feline
- Equine
- Others
- Global Companion Animal Vaccine Market, By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institute
- Others
- Global Companion Animal Vaccine Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck & Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health
- Croda International Plc
- KM Biologics
- Indian Immunological Ltd.
- Sinovac
- Kyoto Biken vLaboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Species Type
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product Launches/Approvals
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Companion Animal Vaccine Market, By Product Type, 2020- 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Attenuated Live Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trend
- Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trend
5. Global Companion Animal Vaccine Market, By Species Type, 2020- 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Canine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Feline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Equine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Avians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
6. Global Companion Animal Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
7. Global Companion Animal Vaccine Market, By Region, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Elanco Animal Health Incorporated
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ceva Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Virbac
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Zoetis Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- HIPRA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Biogenesis Bago
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ourofino Animal Health.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Croda International Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- KM Biologics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Indian Immunologicals Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sinovac
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Kyoto Biken Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- HESTER BIOSCIENCES LIMITED
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Calier
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bioveta, a.s
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Elanco Animal Health Incorporated
9. Section
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
兽用疫苗市场－全球产业规模、份额、趋势、机会和预测（按疫苗类型、技术、地区和竞争细分，2020-2030 年）家禽疫苗市场－全球产业规模、份额、趋势、机会及预测（按应用、产品、疾病类型、地区和竞争细分，2020-2030 年）
全球新城疫疫苗市场规模（依疫苗类型、品种、区域范围和预测）全球牲畜疫苗市场规模，依疫苗类型、目标动物种类、给药方式、最终用户、区域范围及预测全球家禽疫苗市场规模（依产品类型、疾病类型、剂型、应用、地区、范围和预测）全球猪环状病毒疫苗市场规模（按疫苗类型、最终用户、分销管道、区域覆盖范围和预测）全球猪疫苗市场规模（按适应症、技术、地区和预测）
牲畜疫苗市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测伴侣动物疫苗市场规模、份额、趋势分析报告：按动物类型、产品、给药途径、分销管道、产品、地区、细分预测，2025-2030 年伴侣动物疫苗市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测
▼